e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Tuberculosis transmission and screening strategies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immune reactive profiling in subjects at risk of latent tuberculosis infection with TST(+)/IGRA(-) results.
P. Escalante (Rochester, MN, United States of America), T. Peikert (Rochester, MN, United States of America), V. Van Keulen (Rochester, MN, United States of America), C. Erskine (Rochester, MN, United States of America), A. Limper (Rochester, MN, United States of America)
Source:
International Congress 2018 – Tuberculosis transmission and screening strategies
Session:
Tuberculosis transmission and screening strategies
Session type:
Poster Discussion
Number:
5274
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Escalante (Rochester, MN, United States of America), T. Peikert (Rochester, MN, United States of America), V. Van Keulen (Rochester, MN, United States of America), C. Erskine (Rochester, MN, United States of America), A. Limper (Rochester, MN, United States of America). Immune reactive profiling in subjects at risk of latent tuberculosis infection with TST(+)/IGRA(-) results.. 5274
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Characterization of the HBHA response in TB patients with or without HIV infection.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
The set of immunological tests for detection of active tuberculosis in children with latent infection
Source: International Congress 2019 – Paediatric tuberculosis
Year: 2019
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Combined phenotypical and functional analysis of
M. tuberculosis
specific immunity for diagnosing active infection and risk assessment in latently infected individuals
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
Latent tuberculosis infection treatment in subjects with autoimmune diseases and T-cell interferon-γ responses
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment
Source: International Congress 2017 – Migrants and screening
Year: 2017
Our experience of T cell assays in the diagnosis of MTB disease and latent infection
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland
Source: Eur Respir J 2005; 26: Suppl. 49, 425s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept